Dawn Ipsen, PharmD – LDN Radio Show July 2023 (LDN; low dose naltrexone)

  Linda Elsegood: Today we’re joined by pharmacist Dr Dawn Ipsen who’s the owner of two pharmacies in Washington state. Kuslers Pharmacy and Clark Pharmacy. Could you tell us what it was that inspired you to become a pharmacist?  Dawn Ipsen: I knew early on as a high schooler that I wanted to have a […]

The Utilization of Low Dose Naltrexone for Chronic Pain (Abstract)

The Utilization of Low Dose Naltrexone for Chronic Pain CNS Drugs 28 July 2023 https://pubmed.ncbi.nlm.nih.gov/37505425/ Naltrexone is a mu-opioid receptor antagonist with a long half-life compared with naloxone. Both of these drugs, along with others, were developed with the intention of reversing the effects of opioid abuse or toxicity. Evidence has also shown that naltrexone […]

Dawn Ipsen, PharmD – LDN Radio Show May 2023 (LDN; low dose naltrexone)

D Today we’re joined by pharmacist Dr Dawn Ipsen who’s the owner of two pharmacies in Washington State, Kuslers Pharmacy and Clark Pharmacy. Could you tell us what it was that inspired you to become a pharmacist?  I knew early on as a high schooler that I wanted to have a doctorate degree in something […]

Surmounting withdrawal to initiate fast treatment with naltrexone (SWIFT)… (Abstract)

Surmounting withdrawal to initiate fast treatment with naltrexone (SWIFT): A stepped wedge hybrid type 1 effectiveness-implementation study Contemp Clin Trials 15 March 2023 https://pubmed.ncbi.nlm.nih.gov/36931426/ Background: Extended-release injectable naltrexone (XR-NTX) is an effective treatment for opioid use disorder (OUD), but initiation remains a barrier to implementation. Standard practice requires a 10- to 15-day inpatient admission prior […]